Data presented at the American Transplant Congress 2026 reports transvenous phrenic nerve stimulation reduced lung collapse and significantly increased availability of lungs that meet transplant criteria versus contemporary historical controls EXTON, Pa., June 23, 2026 (GLOBE NEWSWIRE) — Lungpacer Medical Inc., a medical technology company focused on neurostimulation therapies for critically ill patients, announced results [...]